Position in MDGL
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$34,901
-$10,117 QoQ
Shares Held
65
-24.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#342
of 411 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EASTERN BANK holds $42,864,501 across 26 Biotechnology names. MDGL ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
694,925 | $38,964,444 | |
| 2 | VERA |
Vera Therapeutics, Inc.
|
56,050 | $2,418,557 | |
| 3 | MRNA |
Moderna, Inc.
|
14,578 | $1,020,896 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
305 | $151,502 | |
| 5 | 604 | $74,594 | |||
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57 | $35,541 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
65 | $34,901 | |
| 8 | ARGX |
Argenx SE
|
34 | $31,544 |
All Filings in MDGL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,901 | 65 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $45,018 | 86 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $50,081 | 86 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $29,812 | 65 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $19,671 | 65 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $21,529 | 65 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $20,057 | 65 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $13,794 | 65 | Shares | Sole | 2024-10-21 | |
| No filing history on record for this holder in this stock. | ||||||